ecancermedicalscience

Conference Report

Eurocan Platform meeting: European recommendations for biomarker-based chemoprevention trials

8 Dec 2014
Linda Cairns

Chemoprevention or the now more preferred ‘cancer prevention’ is the long-term administration of a biological or chemical agent to reduce the risk of cancer. This approach has long been active in individuals at high risk of developing breast or colon cancer. The aim of this expert meeting was to review the current status of the field of cancer prevention and potential, emerging biomarkers specifically focusing on breast, colon, and lung cancer but also with sessions on ovary and prostate.

Related Articles

Salem Ouaddane Alami, Fatima-Zahra Abdelli, Samia Khalfi, Zenab Alami, Touria Bouhafa
Renata D’Alpino Peixoto, Gabriel Prolla, Anelisa Kruschewsky Coutinho, Julia Andrade de Oliveira, Virgilio Souza e Silva, Rachel Riechelmann, Juliana Florinda de Mendonça Rego, Victor Hugo Fonseca de Jesus, Rui Fernando Weschenfelder
Arunah Chandran, Ishu Kataria, Kunal Oswal, Rita Isaac, Meritxell Mallafré-Larrosa, Sathishrajaa Palaniraja, Rajaraman Swaminathan, Rohit Rebello, Nandimandalam Venkata Vani, Bindhya Vijayan, Moni Kuriakose, Arnie Purushotham, Rengaswamy Sankaranarayanan, Jerard Selvam, Richard Sullivan, Partha Basu
Erick R Vásquez-Jaico, Edgar Fermín Yan-Quiroz, Nicol Bonilla-Feria, Mery Nancy Villarreal Gonzalez, Luis Salas Guzmán, Gustavo Adolfo Vásquez-Tirado, Victor Serna-Alarcon
Chalothorn Wannaphut, Phuuwadith Wattanachayakul, Sakditad Saowapa, Ben Ponvilawan, Manasawee Tanariyakul, Jakrin Kewcharoen, Pitchaporn Yingchoncharoen, Thanathip Suenghataiphorn, Noppawit Aiumtrakul, Jared Acoba